实施高质量的痴呆症护理导航的框架:来自阿尔茨海默症协会痴呆症护理导航圆桌会议的建议
Morgan Daven1, David M Bass2, Nicole Deaner1
1Alzheimer's Association, Chicago, Illinois, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|January 30, 2026
概括
痴呆症护理导航 (DCN) 圆桌会议制定了培训标准,并定义了提高痴呆症护理质量的角色. 建议侧重于以个人和家庭为中心的方法,并为DCN服务创建可持续的金融模式.
科学领域:
- 老年学是一门学科.
- 医疗保健管理的管理
- 痴呆症护理 痴呆症护理 痴呆症护理
背景情况:
- 阿尔茨海默病协会在2023年召开了痴呆症护理导航 (DCN) 圆桌会议.
- 圆桌会议由各种痴呆症专家组成,以指导DCN服务实施.
研究的目的:
- 提高以个人和家庭为中心的痴呆症护理导航 (DCN) 服务的质量,培训和财务可行性.
- 为实施DCN的组织提供战略指导.
主要方法:
- 在DCN圆桌会议中,专家达成共识和进行战略讨论.
- 将DCN服务与医疗保险的指导和改进痴呆体验 (GUIDE) 模型保持一致.
- 基于GUIDE模型和DCN的7个基本原则的建议.
主要成果:
- 确定了DCN增强的关键领域:定义导航者角色,建立培训标准和开发可持续的商业案例.
- 澄清了导航员的职责,并鼓励社区合作伙伴参与.
- 为所有痴呆症护理团队成员推全面培训.
结论:
- 定义的角色和标准化的培训对于高质量的痴呆症护理导航 (DCN) 是至关重要的.
- 可持续的商业案例需要向付款人展示价值,并与医疗保健指标保持一致.
- 以个人和家庭为中心的护理原则应指导所有DCN实施.
相关概念视频
Documentation in Long-Term and Home Healthcare Setting
1.6K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.6K
Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Dementia
696
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
696
Alzheimer Disease l: Introduction
38
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
38
Dementia l: Introduction
35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35


